Similar to the findings of studies by Lai et al. and Kishiro et al. reporting considerably higher levels of serum VEGF in primary NSCLC patients than in controls without cancer, significantly increased serum VEGF levels in NSCLC patients were noted also in the present study [24,25]. Here, VEGFA is linked to non-small cell lung carcinoma.